Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Shares Outstanding (Diluted Average) (2016)

Edesa Biotech's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $8.8 million for Q3 2016.

  • For Q3 2016, Shares Outstanding (Diluted Average) changed N/A year-over-year to $8.8 million; the TTM value through Sep 2016 reached $8.8 million, changed N/A, while the annual FY2016 figure was $8.8 million, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2016 was $8.8 million at Edesa Biotech, up from $8.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $79.5 million in Q4 2014 and bottomed at $5.2 million in Q3 2013.
  • The 4-year median for Shares Outstanding (Diluted Average) is $8.4 million (2016), against an average of $27.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) skyrocketed 46.92% in 2014 before it grew 5.93% in 2016.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $74.0 million in 2013, then grew by 7.41% to $79.5 million in 2014, then tumbled by 89.99% to $8.0 million in 2015, then grew by 11.0% to $8.8 million in 2016.
  • Per Business Quant, the three most recent readings for EDSA's Shares Outstanding (Diluted Average) are $8.8 million (Q3 2016), $8.4 million (Q2 2016), and $8.0 million (Q2 2015).